Evidence map›Paper›PMID 37301983›Full record

ArticleJournal of radiation research2023

Salvage high-dose rate brachytherapy for myxofibrosarcoma of the brachium: a technical report.

Naoya Murakami, Fumihiko Nakatani, Kana Takahashi, Satoshi Nakamura, Hiroshi Igaki, Naoto Shikama

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of radiation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Naoya MurakamiDepartment of Radiation Oncology, Juntendo University School of Medicine, 3-1-3, Bunkyo-ku, Tokyo 113-8431, Japan.
Fumihiko NakataniDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital East, 6-5-1, Kashiwa-shi, Chiba 277-8577, Japan.
Kana TakahashiDepartment of Radiation Oncology, Juntendo University School of Medicine, 3-1-3, Bunkyo-ku, Tokyo 113-8431, Japan.
Satoshi NakamuraDivision of Radiation Safety and Quality Assurance, National Cancer Center Hospital, 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Hiroshi IgakiDepartment of Radiation Oncology, Juntendo University School of Medicine, 3-1-3, Bunkyo-ku, Tokyo 113-8431, Japan.
Naoto ShikamaDepartment of Radiation Oncology, National Cancer Center Hospital, 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Juntendo University · JPNational Cancer Center Hospital East · JPTokyo National Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An 80-year-old male presented with T1N0M0 myxofibrosarcoma in or next to the humeral canal, which is located between the biceps and triceps of the right upper arm. Because the tumor was close to critical anatomical structures such as the brachial artery, median nerve and ulnar nerve, it was deemed impossible to perform limb-sparing surgery with an adequate resection margin. Therefore, preoperative external beam radiation therapy (EBRT) followed by limb-sparing surgery was offered. Magnetic resonance imaging taken after 40 Gy/20 fractions of EBRT showed an inadequate response, and limb-sparing surgery was not deemed possible at this point. Amputation of the right arm was offered, but the patient refused. Therefore, salvage high-dose-rate interstitial brachytherapy (HDR-ISBT) was offered. Under local anesthesia and sedation, 14 plastic needles were inserted, and 36 Gy in 6 fractions of HDR-ISBT was performed. Although radiation-induced incomplete paralysis of the median nerve was noted, no local progression or distant metastasis was found on the CT that was taken 2 years after the treatment.

Indexed as

ArmBrachytherapyAged, 80 and overHumansMaleRadiotherapy Dosage

Identifiers

PMID37301983
PMCPMC10354856
OpenAlexW4380224976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.